Since 2018: Senior Postdoctoral Fellow, Department of Immunology, Monash University, Melbourne,       Australia. 2014-2018: Research Fellow, Immunodeficiency and Immunology laboratory, Garvan Institute of Medical Research, Sydney, Australia. 2011-2013: Research Fellow, Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Emily’s research focuses on identifying the genetic and functional defects underlying predominantly antibody deficiency. Emily was the 2022 recipient of the Grifols ASPIRE (Award for Scientific Progress in Immunodeficiency Research) Award, which enabled her to develop and standardize functional tests,and new bioinformatic analysis pipelines to facilitate this work. Emily received the 2022 AIFA Primary Immunodeficiency Clinical Research Grant to examine the SARS-CoV-2-specific antibody levels and neutralization capacity of Australian Immunoglobulin product. Her research also includes examination of SARS-CoV-2-specific immune responses to COVID-19 vaccination in these patients. Emily is the current Vice President of the Australian Primary Immunodeficiency patient advocacy and support organization AusPIPS, and a member of The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies. Her dual role as a patient advocate and researcher has led to her inclusion in the Global World Primary Immunodeficiency Week Campaigns in 2022 and 2023.